Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03883880 · ClinicalTrials.gov registry record · NA
Salivary Interactions With Chemosensations
A NA study, sponsored by Purdue University.
- Terminated
- Registry status
- NA
- Development phase
- 32
- Enrollment target
NCT03883880 is a NA study that was terminated before completion, run by Purdue University. The registered enrollment target is 32 participants.
The verdict
NCT03883880, a NA study, was terminated before completion, sponsored by Purdue University.
- TERMINATED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
Study Summary
A counterbalanced, crossover design will be used to evaluate whether exposure to flavors vs. a control over time alters the perception of the flavor by changing an individual's salivary protein profile. Participants will complete 3 acute tasting protocols (baseline, after intervention 1, after intervention 2). The interventions will be with the flavor (epigallocatechin gallate, linolenic acid, capsaicin) or a control, in counterbalanced order, and will involve swishing and swallowing a solution of that sample 5 times per day for two weeks. Each of these flavors will be a separate sub-study.
Interventions
- OTHER Epigallocatechin gallate
- OTHER Epigallocatechin gallate control
- OTHER Linoleic acid
- OTHER Linoleic acid control
- OTHER Capsaicin solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2019-01-05 |
| Est. Completion | 2021-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03883880
The ClinicalTrials.gov registry entry for NCT03883880 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Purdue University, which has 141 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Epigallocatechin gallate is the first listed.
NCT03883880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03883880 about?
NCT03883880 is a clinical study titled "Salivary Interactions With Chemosensations". A counterbalanced, crossover design will be used to evaluate whether exposure to flavors vs. a control over time alters the perception of the flavor by changing an individual's salivary protein profile. Participants will complete 3 acute tasting protocols (baseline, after intervention 1, after inter...
What is the current status of trial NCT03883880?
This trial is currently terminated. It is a NA study. The enrollment target is 32 participants. The study started on 2019-01-05. Estimated completion is 2021-12-01.
What interventions are being tested in trial NCT03883880?
The interventions under investigation include: Epigallocatechin gallate (OTHER), Epigallocatechin gallate control (OTHER), Linoleic acid (OTHER), Linoleic acid control (OTHER), Capsaicin solution (OTHER).
Who is sponsoring clinical trial NCT03883880?
This trial is sponsored by Purdue University, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.